Lifeboat Foundation

This post is also available in: עברית (Hebrew)

A revolutionary brain implant invented by a team of neuroscientists, neurosurgeons, and engineers can transform thoughts into speech. This technology will hopefully help people who cannot speak because of neurological conditions be able to communicate once more.

Gregory Cogan, a professor of neurology at Duke University’s School of Medicine and one of the lead researchers in the project, explains: “There are many patients who suffer from debilitating motor disorders, like Amyotrophic Lateral Sclerosis (ALS) or locked-in syndrome, that can impair their ability to speak… But the current tools available to allow them to communicate are generally very slow and cumbersome.”

In an interesting revelation, a collaborative team of researchers across various institutions in London has shown that rocket scientists and neurosurgeons, who are often held on a high pedestal for their superior intellect are, in fact, no smarter than the general public, BBC reported.

When failing to complete day-to-day tasks, one often comes across the term “It’s not rocket science”. The phrases that have been used by the public at large tacitly imply that rocket science or brain surgery is not a menial job and requires an individual of a higher intellect. Interestingly, it was a team of neurosurgeons and those involved in studying the human brain who decided to probe whether this held true.

Treating mental disorders with fewer side effects

Now, researchers have managed to genetically modify yeast cells to produce drugs for mental disorders such as schizophrenia with fewer side effects.

“Development of medicines from natural plant substances is widely used. However, since plants do not produce these substances to fight human diseases, there is often a need to modify them to make them more effective and safe,” said Michael Krogh Jensen, a senior researcher at DTU Biosustain and co-founder of the biotech company Biomia.

The challenge of measuring adult neurogenesis is difficult, but it’s not impossible. A big part of the solution is knowing what to measure and where. While this new study was performed on rats—and therefore may be a poor predictor of what we’ll see in humans—it can direct future research by showing neuroscientists where to look and what to look for.

And unlike the hard problem of consciousness, unraveling the mysteries of adult neurogenesis may have clinical applications. Better the lifecycle of neurons may reveal how neurological disorders such as Parkinson’s and Alzheimer’s disease emerge. There’s even research linking disorders such as depression and anxiety to neurogenesis activity.

Continue reading “Adult-made neurons mature longer, have unique functions” »

Only 2% of Alzheimer’s is 100% genetic. The rest is up to your daily habits.

Up Next ► 4 ways to hack your memory https://youtu.be/SCsztDMGP7o.

Continue reading “5 ways to build an Alzheimer’s-resistant brain | Lisa Genova” »

In 2008, Dr. Eben Alexander contracted a rare case of bacterial meningitis. As the pathogen wracked his brain, causing it to swell and suffuse with pus, Alexander entered a deep coma. He was not expected to survive. But live he did, and with a tale to tell. For in Alexander’s stricken state, he underwent a near-death experience, a profound out-of-body event. Four years later, the neurosurgeon detailed it in a best-selling book.

“I had no real center of consciousness,” he wrote. “I didn’t know who or what I was or even if I was simply… there, a singular awareness in the midst of a soupy, dark, muddy nothingness…”

More recently, Alexander’s popular account of his near-death experience attracted the attention of Pascal Michael, a PhD student in psychology at the University of Greenwich. Michael met Alexander after seeing him speak at an academic conference and was informed that Alexander had experimented with 5-MeO-DMT, a psychedelic closely related to DMT, secreted from the glands of the Colorado River toad.

The amygdala can hijack your brain’s response if it recognizes past trauma in a current situation. To regain control, simply press pause. Big Think.

DBS delivers electric currents to an electrode implanted in the brain.

Neurotechnology – or – while still an emerging industry, has attracted both major capital investments, and extensive media coverage in recent years. As tech relentlessly searches for the next “big tech platform” in the aftermath of the smartphone era [1], we propose that the answer may lie within our own minds. At NTX Services, we definenology as any technological intervention that interacts with the brain or central nervous system either directly or indirectly, and as attempts to integrate human and machine to enhance both, applications of the technology are broad ranging.

Often described as a new field, is actually based on decades of academic research, previously held back from commercialization at scale due to technological limitations, and slow changes in government policies and regulations. Although humans have been researching the brain and its bioelectrical signals since the 1600s [2], the first major breakthrough in was the invention of the electroencephalogram (EEG) by Hans Berger in 1929 [3]. Since this initial invention, several key developments have influenced the evolution of the industry until 2016, when Neuralink was founded [4].

It is increasingly clear that memories are distributed across multiple brain areas. Such “engram complexes” are important features of memory formation and consolidation. Here, we test the hypothesis that engram complexes are formed in part by bioelectric fields that sculpt and guide the neural activity and tie together the areas that participate in engram complexes. Like the conductor of an orchestra, the fields influence each musician or neuron and orchestrate the output, the symphony. Our results use the theory of synergetics, machine learning, and data from a spatial delayed saccade task and provide evidence for in vivo ephaptic coupling in memory representations.